Cheek pouch could change how Parkinson's drugs are taken

NCT ID NCT07709741

First seen Jul 16, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests a new way to deliver two common Parkinson's medications, carbidopa and levodopa, using a small pouch placed between the cheek and gum. The pouch releases the drugs slowly, allowing absorption through both the cheek lining and the stomach. Researchers are measuring drug levels in the blood of healthy volunteers to see how well this method works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combination of carbidopa and levodopa in a special pouch that releases the drugs slowly through the cheek lining and stomach
What this could lead to
If successful, this approach could lead to a more convenient way for people with Parkinson's to take their medication, potentially improving symptom control.
What could go wrong
This is an early-stage study in healthy volunteers, so it does not yet test whether the formulation actually improves Parkinson's symptoms. The results may not translate to patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.